| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |